Skip to main content
TipRanks
Go Ultimate75% OFF
TRexBio Inc logo

TRexBio Inc: Valuation, Funding & Investors

681 Gateway Blvd 4th Floor South San Francisco, California 94080, UShttps://www.trex.bio/Therapeutics

TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue-resident regulatory T cell (Treg) biology. The company leverages computational biology and a proprietary Deep Biology Platform to map human tissue Treg behavior and advance tissue-targeted therapies for autoimmune and inflammatory diseases.

Leadership & Board

Current Number of Employees
62
Current LinkedIn Followers
13,559

Latest Estimated Valuation

Total Amount Raised
$50M
Total Funding Rounds
1
Latest Funding Amount
$50M
Latest Funding Round
Investment

Company Momentum

Positive
Articles Published on TipRanks1
LinkedIn Trend+0.30% followers
Workforce Trend+0.0% employees

TRexBio Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.

Employee Trend

TRexBio Inc had 62 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

62Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

TRexBio Inc had 13,559 followers as of November 16, 2026. The number of followers increased by 41 (0.30%) week-over-week.

13,559Latest Followers Count
41(0.30%)Week-Over-Week Change
05,00010,00015,00020,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 27, 2026Investment$50.00M―

Investors

Similar Companies

A snapshot of private companies similar to TRexBio Inc, helping you discover and navigate related company profiles.

Related News and Analysis